BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18227567)

  • 1. Gastrointestinal stromal tumor--paradigm for successful targeted therapy.
    Kurian S
    Indian J Gastroenterol; 2007; 26(5):207-8. PubMed ID: 18227567
    [No Abstract]   [Full Text] [Related]  

  • 2. Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    ESMO / European Sarcoma Network Working Group
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii49-55. PubMed ID: 22997454
    [No Abstract]   [Full Text] [Related]  

  • 3. Downstaging of a rectal gastrointestinal stromal tumor by neoadjuvant imatinib therapy allowing for a conservative surgical approach.
    Santos Fernandes Gd; Castro Cotti GC; Freitas D; Cutait R; Hoff PM
    Clinics (Sao Paulo); 2009; 64(8):819-21. PubMed ID: 19690669
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of resectable gastrointestinal stromal tumor.
    Chaudhry UI; DeMatteo RP
    Hematol Oncol Clin North Am; 2009 Feb; 23(1):79-96, viii. PubMed ID: 19248972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of gastrointestinal stromal tumors before and after imatinib mesylate therapy.
    Shankar S; Dundamadappa SK; Karam AR; Stay RM; van Sonnenberg E
    Acta Radiol; 2009 Oct; 50(8):837-44. PubMed ID: 19735005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gastrointestinal stromal tumor of the ileum with metastatic relapse developed in the mesentery].
    Raherinantenaina F; Rasoaherinomenjanahary F; Francine AT; Rambel AH; Rantomalala HY; Samison LH; Ratsimba HN
    Pan Afr Med J; 2014; 18():18. PubMed ID: 25360202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic changes in advanced gastrointestinal stromal tumor (GIST) patients during imatinib mesylate treatment.
    Yeh CN; Chen TW; Liu FY; Jan YY; Chen MF
    Langenbecks Arch Surg; 2006 Nov; 391(6):615-21. PubMed ID: 17024483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Imaging follow-up of gastrointestinal stromal tumors (GIST) during therapy: a case report].
    Demuynck F; Morvan J; Brochart C; Blanpain S; Brasseur A; Fuks D; Robert B; Chatelain D; Yzet T
    J Radiol; 2009 Jun; 90(6):735-8. PubMed ID: 19623127
    [No Abstract]   [Full Text] [Related]  

  • 9. Imatinib mesylate as therapy for gastrointestinal stromal tumor.
    Peshwe HB; Chatni S; Basu S
    Indian J Gastroenterol; 2005; 24(4):188. PubMed ID: 16204927
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment with sunitinib in a young patient with metastatic gastrointestinal stromal tumor after failure on adjuvant imatinib.
    Kapoor R; Khosla D; Kumar P; Kumar N; Bera A
    J Cancer Res Ther; 2011; 7(4):491-3. PubMed ID: 22269418
    [No Abstract]   [Full Text] [Related]  

  • 11. Imaging characteristics of liver metastasis from gastrointestinal stromal tumor before and after imatinib mesylate treatment.
    Ulusan S; Koç Z; Kayaselçuk F
    Turk J Gastroenterol; 2008 Jun; 19(2):129-32. PubMed ID: 19110671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical aspects of managing gastrointestinal stromal tumors.
    Sleijfer S; Seynaeve C; Wiemer E; Verweij J
    Clin Colorectal Cancer; 2006 Nov; 6 Suppl 1():S18-23. PubMed ID: 17101064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Etiology of and therapy for gastrointestinal stromal tumor].
    Shinomura Y
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1939-45. PubMed ID: 17037339
    [No Abstract]   [Full Text] [Related]  

  • 14. Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    ; Blay JY; Le Cesne A
    Ann Oncol; 2007 Apr; 18 Suppl 2():ii27-9. PubMed ID: 17491033
    [No Abstract]   [Full Text] [Related]  

  • 15. Critical update and emerging trends in imatinib treatment for gastrointestinal stromal tumor.
    De Giorgi U; Pupi A; Turrisi G; Montenora I; Morini S; Fayyaz M; De Simone M; Fiorentini G
    Rev Recent Clin Trials; 2007 Jan; 2(1):43-8. PubMed ID: 18473987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal stromal tumors: a single institution experience of 50 cases.
    Rajappa S; Muppavarapu KM; Uppin S; Digumarti R
    Indian J Gastroenterol; 2007; 26(5):225-9. PubMed ID: 18227573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib resistance in gastrointestinal stromal tumors.
    Chen LL; Sabripour M; Andtbacka RH; Patel SR; Feig BW; Macapinlac HA; Choi H; Wu EF; Frazier ML; Benjamin RS
    Curr Oncol Rep; 2005 Jul; 7(4):293-9. PubMed ID: 15946589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy and target-therapy of gastrointestinal tumors call for development of pathology].
    Shen L
    Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):438-9. PubMed ID: 17845753
    [No Abstract]   [Full Text] [Related]  

  • 19. [Molecular and histologic characteristics of secondary imatinib-resistant gastrointestinal stromal tumors].
    Zheng S; Jia J; Pan YL; Tao DY; Lu HS
    Zhonghua Bing Li Xue Za Zhi; 2013 Jan; 42(1):42-3. PubMed ID: 23611272
    [No Abstract]   [Full Text] [Related]  

  • 20. Neoadjuvant therapy with imatinib mesylate for locally advanced GI stromal tumor.
    Shah JN; Sun W; Seethala RR; Livolsi VA; Fry RD; Ginsberg GG
    Gastrointest Endosc; 2005 Apr; 61(4):625-7. PubMed ID: 15812427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.